A 43-year-old smoker with a past medical history of asthma arrives at the clinic with reports of a cough and breathlessness with an inability to speak in full sentences. On examination, the patient is tachypneic and tachycardic, with audible wheezing. The pulse oximetry reading is 86% on room air. Which emergency medication is imperative for the clinic to have in preparation to manage acute bronchospasm for the case above?

Angiotensin-converting enzyme (ACE) inhibitors are primarily used to manage hypertension and heart failure rather than respiratory conditions. They do not provide any bronchodilation and are not indicated in acute asthma exacerbations. Therefore, they are not useful in the management of bronchospasm.

Salmeterol is a long-acting B-agonist used for maintenance therapy in asthma but is not suitable for immediate relief of acute bronchospasm. Its delayed onset of action means it cannot address the urgent need for bronchodilation in an acute setting, making it ineffective for this emergency situation.

Propranolol is a non-selective beta-blocker that can actually exacerbate bronchospasm by blocking beta-2 adrenergic receptors in the lungs. It is contraindicated in patients with asthma or reactive airway diseases and does not provide any therapeutic benefit in the context of an acute asthma attack.